BIPOC individuals bear greater post-COVID health burdens, new research suggests

Black, indigenous, and people of color (BIPOC) who were infected with COVID-19 experienced greater negative aftereffects in health and work loss than did similarly infected white participants, new research finds.

Residents of Rural ‘Glades’ Take a ‘Leap of Faith’ to Combat Dementia

Compared to urban dwellers, racially/ethnically diverse older adults face up to an 80 percent greater risk of cognitive impairment in older age, and 2.5 times potentially preventable Alzheimer’s-related (ADRD) hospitalizations.

Physicians Should Screen Youth for Cyberbullying, Social Media Use

Researchers recommend primary care physicians screen adolescents and young adults for inappropriate or misuse of social media and cyberbullying utilizing screening tools developed for use in the health care setting. Physicians also can ask about the many symptoms that could be warning signs of cyberbullying such as sleep disorders, mood disorders, eating disorders, suicidal thoughts, self-harm behaviors, academic problems, fatigue and headaches. They also can undergo training to detect bullying and ensure that their staff is trained appropriately.

AI Model Proactively Predicts if a COVID-19 Test Might be Positive or Not

Researchers trained five classification algorithms to create an accurate model to predict COVID-19 test results. Results identify the key symptom features associated with COVID-19 infection and provide a way for rapid screening and cost effective infection detection. Findings reveal that number of days experiencing symptoms such as fever and difficulty breathing play a large role in COVID-19 test results. Findings also show that molecular tests have much narrower post-symptom onset days compared to post-symptom onset days of serology tests. As a result, the molecular test has the lowest positive rate because it measures current infection.

Landmark Study of Biomarker Data May Enable Better Treatment for Early Onset Dementia

In a study publishing in Nature Medicine on September 22, 2022, University of California San Francisco researchers Adam Staffaroni, PhD, and Adam Boxer, MD, PhD, combined and harmonized clinical, neuroimaging, and fluid biomarkers from nearly all familial FTD clinical research participants across North America and Europe. With that data, they developed models of clinical and biomarker dynamics to determine the temporal sequence of biomarker and clinical changes in f-FTD before disease progression begins.

New Oral Antiviral Drug Reduces Death in Early COVID-19

Researchers note that health care providers are now able to add to their armamentarium against COVID-19 their prescription of this new antiviral drug for high-risk, newly-infected patients as soon as possible following diagnosis or within five days of the onset of symptoms.

UCLA to lead CDC-funded study testing effectiveness of vaccines on health workers

Researchers will study vaccinated and non-vaccinated health workers who get tested for the virus after experiencing common COVID-19 symptoms like fever, cough or a loss of sense of taste or smell. They will compare the incidence of positive tests and severity of illness in those who test positive.

Mount Sinai Study Finds Wearable Devices Can Detect COVID-19 Symptoms and Predict Diagnosis

Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, according to a Mount Sinai study.

Rutgers Expert Available to Comment on COVID-19 Neurological Effects in Seniors

Dr. XinQi Dong, MD, MPH, director of the Institute for Health, Health Care Policy and Aging Research at Rutgers University-New Brunswick, is available to comment on the importance of further research into neurological effects of COVID-19 that may be related…

COVID-19 Appears Less Severe in Children, Says Review in Pediatric Infectious Disease Journal

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there’s reassuring evidence that children have fewer symptoms and less severe disease. That’s among the insights provided by an expert review in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

COVID-19 Appears Less Severe in Children, Says Review in Pediatric Infectious Disease Journal

As outbreaks of COVID-19 disease caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue worldwide, there’s reassuring evidence that children have fewer symptoms and less severe disease. That’s among the insights provided by an expert review in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.